The FDA (Food and Drugs Administration) in charge of regulating the American market has just accepted the sale of the G7 of the Dexcom brand. This connected “patch” is very useful for people with diabetes.
The company now hopes that the product will be available almost everywhere on American soil during the year 2023. The patch is presented as an effective solution once morest all types of diabetes. It has the best glucose level calculation system on the market today. The product also offers the ability to connect live with an Apple Watch or third-party health apps. This allows for easier and faster access to the data collected.
© Dexcom
Dexcom explains that this new model (G7) is 60% smaller than previous products. The system is now very efficient. It is able to predict 20 minutes in advance a too low glucose level. In people with diabetes, this glucose level must be closely monitored to avoid hypoglycaemia.
Glucose level analysis is a very important feature for healthcare products. Apple has been working for years to offer such a sensor within its Apple Watch. This feature would be a game changer for the 500 million people with diabetes worldwide.
Apple has been working on this solution for years
With the latest Apple Watch Series 8, the Apple brand does not yet offer solutions, but numerous patents of the firm have already been made public. They show a growing interest around this question on the side of Cupertino. Already capable of measuring heart rate, oxygenation rate or even performing an ECG, the Apple Watch is one of the most advanced health companions in the world.
The question of managing people with diabetes is on everyone’s lips today, with this feature being my next big step in the development of the watch.
By: Keleops AG